Emil J. Freireich is conducting research in International Prognostic Scoring System and Refractory anemia as part of his Myelodysplastic syndromes study. His Refractory anemia study frequently intersects with other fields, such as Myelodysplastic syndromes. His study on Internal medicine is mostly dedicated to connecting different topics, such as Transplantation. Transplantation connects with themes related to Internal medicine in his study. He undertakes interdisciplinary study in the fields of Oncology and Gastroenterology through his works. Borrowing concepts from Oncology, Emil J. Freireich weaves in ideas under Gastroenterology. His Immunology study frequently links to adjacent areas such as Myeloid. He merges Myeloid with Leukemia in his study. Emil J. Freireich frequently studies issues relating to Preleukemia and Leukemia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia
Gerald P. Bodey;Monica Buckley;Y. S. Sathe;Emil J Freireich.
Annals of Internal Medicine (1966)
Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion.
Sewa S. Legha;Robert S. Benjamin;Bruce Mackay;Michael Ewer.
Annals of Internal Medicine (1982)
The quantitative relation between platelet count and hemorrhage in patients with acute leukemia.
Lawrence A. Gaydos;Emil J. Freireich;Nathan Mantel.
The New England Journal of Medicine (1962)
Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification
Ming Sheng Lee;Kun Sang Chang;Fernando Cabanillas;Emil J. Freireich.
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.
Hagop M Kantarjian;Varsha Gandhi;Jorge Cortes;Srdan Verstovsek.
Cellular DNA content as a marker of neoplasia in man.
Barthel Barlogie;Benjamin Drewinko;Johannes Schumann;Wolfgang Göhde.
The American Journal of Medicine (1980)
IMVP-16: An Effective Regimen for Patients With Lymphoma Who Have Relapsed After Initial Combination Chemotherapy
Fernando Cabanillas;Fredrick B. Hagemeister;Gerald P. Bodey;Emil J. Freireich.
Causes of death in adults with acute leukemia.
Hui Yen Chang;Victorio Rodriguez;Gino Narboni;Gerald P. Bodey.
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients
Hagop M. Kantarjian;Michael J. Keating;Moshe Talpaz;Ronald S. Walters.
The American Journal of Medicine (1987)
Characteristics of accelerated disease in chronic myelogenous leukemia.
Hagop M. Kantarjian;Dennis Dixon;Michael J. Keating;Moshe Talpaz.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: